Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanoma - Archive ouverte HAL Access content directly
Journal Articles European Journal of Cancer Year : 2019

Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanoma

Fichier principal
Vignette du fichier
S0959804918315612.pdf (3.95 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03486195 , version 1 (20-12-2021)

Licence

Attribution - NonCommercial

Identifiers

Cite

Caroline Robert, Keith Flaherty, Paul Nathan, Peter Hersey, Claus Garbe, et al.. Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanoma. European Journal of Cancer, 2019, 109, pp.61 - 69. ⟨10.1016/j.ejca.2018.12.015⟩. ⟨hal-03486195⟩

Collections

UNIV-FCOMTE
4 View
116 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More